German BioTech iDEL Therapeutics lands €9 million to develop cancer therapeutics platform | EU-Startups
Dortmund-based iDEL Therapeutics announced the closing of a €9 million Seed financing, to develop a pipeline of cancer therapeutics that are delivered directly into the cytosol of tumor cells. The ...
Source: EU-Startups
Dortmund-based iDEL Therapeutics announced the closing of a €9 million Seed financing, to develop a pipeline of cancer therapeutics that are delivered directly into the cytosol of tumor cells. The financing was led by BiomedVC with participation from NRW.Venture, Gründerfonds Ruhr and the KHAN Technology Transfer Fund II. “iDEL Therapeutics’ concept to unlock new cancer […]